Global and China Therapeutic Proteins and Oral Vaccines Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Therapeutic Proteins and Oral Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Merck

    • MigVax

    • Novo Nordisk

    • Emergent Biosolutions

    • Roche

    • Sanofi

    • Abbott

    • TransAlgae

    • Biogen

    • Serum Institute of India

    • Pfizer

    • Lumen Bioscience

    • Johnson and Johnson

    • Amgen

    • Eli Lilly and Company

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Therapeutic Proteins

    • Oral Vaccines

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Therapeutic Proteins and Oral Vaccines Industry Overview

      • 1.1.1 Therapeutic Proteins and Oral Vaccines Market Scope and Market Segments

      • 1.1.2 Therapeutic Proteins and Oral Vaccines Industry Characteristics

      • 1.1.3 Global and China Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Therapeutic Proteins and Oral Vaccines Production Value and Growth Rate (2017-2028)

    • 1.2 Global Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Therapeutic Proteins

      • 1.2.2 Oral Vaccines

    • 1.3 Global Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Therapeutic Proteins and Oral Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Therapeutic Proteins and Oral Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Therapeutic Proteins and Oral Vaccines Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Therapeutic Proteins and Oral Vaccines Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Therapeutic Proteins and Oral Vaccines Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Therapeutic Proteins and Oral Vaccines Industry Porter's Five Forces Model Analysis

      • 2.2.3 Therapeutic Proteins and Oral Vaccines Industry PEST Analysis

    • 2.3 Therapeutic Proteins and Oral Vaccines Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Therapeutic Proteins and Oral Vaccines Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Therapeutic Proteins and Oral Vaccines Industry

    Chapter 3 Global and China Therapeutic Proteins and Oral Vaccines Market, by Manufacturer

    • 3.1 Global and China Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Therapeutic Proteins and Oral Vaccines Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Therapeutic Proteins and Oral Vaccines Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Therapeutic Proteins and Oral Vaccines Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Therapeutic Proteins and Oral Vaccines Market Top 3 Players

    Chapter 4 Global and China Therapeutic Proteins and Oral Vaccines Market, by Type (2017-2028)

    • 4.1 Therapeutic Proteins and Oral Vaccines Market Trend, by Type

    • 4.2 Global Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Therapeutic Proteins and Oral Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Therapeutic Proteins and Oral Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Therapeutic Proteins and Oral Vaccines Price Trend, by Type (2017-2028)

    • 4.3 China Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Therapeutic Proteins and Oral Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Therapeutic Proteins and Oral Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Therapeutic Proteins and Oral Vaccines Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Therapeutic Proteins and Oral Vaccines Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Therapeutic Proteins and Oral Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Therapeutic Proteins and Oral Vaccines Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Therapeutic Proteins and Oral Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Therapeutic Proteins and Oral Vaccines Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Therapeutic Proteins and Oral Vaccines Market Analysis

    • 7.1 North America Therapeutic Proteins and Oral Vaccines Market, by Type

    • 7.2 North America Therapeutic Proteins and Oral Vaccines Market, by Application

    • 7.3 North America Therapeutic Proteins and Oral Vaccines Market Analysis and Forecast, by Country

      • 7.3.1 United States Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Therapeutic Proteins and Oral Vaccines Market Analysis

    • 8.1 Europe Therapeutic Proteins and Oral Vaccines Market, by Type

    • 8.2 Europe Therapeutic Proteins and Oral Vaccines Market, by Application

    • 8.3 Europe Therapeutic Proteins and Oral Vaccines Market Analysis and Forecast, by Country

      • 8.3.1 Germany Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Therapeutic Proteins and Oral Vaccines Market Analysis

    • 9.1 APAC Therapeutic Proteins and Oral Vaccines Market, by Type

    • 9.2 APAC Therapeutic Proteins and Oral Vaccines Market, by Application

    • 9.3 APAC Therapeutic Proteins and Oral Vaccines Market Analysis and Forecast, by Country

      • 9.3.1 China Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Analysis

    • 10.1 Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Type

    • 10.2 Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Application

    • 10.3 Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Therapeutic Proteins and Oral Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Therapeutic Proteins and Oral Vaccines Company Profiles

      • 11.1 Merck

        • 11.1.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Merck Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.1.3 Merck Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 MigVax

        • 11.2.1 MigVax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 MigVax Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.2.3 MigVax Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Novo Nordisk

        • 11.3.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.3.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Emergent Biosolutions

        • 11.4.1 Emergent Biosolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.4.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Roche

        • 11.5.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Roche Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.5.3 Roche Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Sanofi

        • 11.6.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Sanofi Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.6.3 Sanofi Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Abbott

        • 11.7.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Abbott Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.7.3 Abbott Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 TransAlgae

        • 11.8.1 TransAlgae Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 TransAlgae Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.8.3 TransAlgae Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Biogen

        • 11.9.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Biogen Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.9.3 Biogen Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Serum Institute of India

        • 11.10.1 Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.10.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Pfizer

        • 11.11.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Pfizer Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.11.3 Pfizer Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Lumen Bioscience

        • 11.12.1 Lumen Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.12.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Johnson and Johnson

        • 11.13.1 Johnson and Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.13.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Amgen

        • 11.14.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Amgen Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.14.3 Amgen Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Eli Lilly and Company

        • 11.15.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Profiles, Application and Specification

        • 11.15.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Therapeutic Proteins and Oral Vaccines Industry Investment Prospect and Risk Assessment

    • 12.1 Therapeutic Proteins and Oral Vaccines Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Therapeutic Proteins and Oral Vaccines Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Production Value and Growth Rate (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Production Value and Growth Rate (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate of Therapeutic Proteins (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate of Oral Vaccines (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Therapeutic Proteins and Oral Vaccines Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Therapeutic Proteins and Oral Vaccines Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Therapeutic Proteins and Oral Vaccines Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Therapeutic Proteins and Oral Vaccines Market Share, by Manufacturer in 2021

    • Figure Global and China Therapeutic Proteins and Oral Vaccines Market Share, by Manufacturer in 2022

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Volume, by Type (2017-2028)

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Value, by Type (2017-2028)

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Value Share, by Type (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Price Trend, by Type (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Volume, by Type (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Value, by Type (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Value Share, by Type (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Price Trend, by Type (2017-2028)

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Volume, by Application (2017-2028)

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Value, by Application (2017-2028)

    • Table Global Therapeutic Proteins and Oral Vaccines Sales Value Share, by Application (2017-2028)

    • Figure Global Therapeutic Proteins and Oral Vaccines Sales Value Share, by Application (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Volume, by Application (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Value, by Application (2017-2028)

    • Table China Therapeutic Proteins and Oral Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure North America Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Production, Import, Consumption and Export (2017-2022)

    • Table North America Therapeutic Proteins and Oral Vaccines Sales Volume, by Type (2017-2028)

    • Table North America Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure North America Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Table North America Therapeutic Proteins and Oral Vaccines Sales Volume, by Application (2017-2028)

    • Table North America Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure North America Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure United States Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure United States Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Canada Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Europe Therapeutic Proteins and Oral Vaccines Sales Volume, by Type (2017-2028)

    • Table Europe Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Europe Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Europe Therapeutic Proteins and Oral Vaccines Sales Volume, by Application (2017-2028)

    • Table Europe Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Europe Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Germany Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure UK Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure UK Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure France Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure France Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Italy Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Spain Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Poland Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Russia Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Table APAC Therapeutic Proteins and Oral Vaccines Sales Volume, by Type (2017-2028)

    • Table APAC Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure APAC Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Table APAC Therapeutic Proteins and Oral Vaccines Sales Volume, by Application (2017-2028)

    • Table APAC Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure APAC Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Japan Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure India Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure India Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Therapeutic Proteins and Oral Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Therapeutic Proteins and Oral Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table MigVax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MigVax Product Profiles, Application and Specification

    • Table MigVax Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emergent Biosolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emergent Biosolutions Product Profiles, Application and Specification

    • Table Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TransAlgae Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TransAlgae Product Profiles, Application and Specification

    • Table TransAlgae Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen Product Profiles, Application and Specification

    • Table Biogen Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute of India Product Profiles, Application and Specification

    • Table Serum Institute of India Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lumen Bioscience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lumen Bioscience Product Profiles, Application and Specification

    • Table Lumen Bioscience Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson and Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson and Johnson Product Profiles, Application and Specification

    • Table Johnson and Johnson Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.